GRX (The Gabelli Healthcare & Wellness Trust) Stock Analysis - AI Report
The Gabelli Healthcare & Wellness Trust (GRX) is a publicly traded Financial Services sector company. As of May 21, 2026, GRX trades at $11.51 with a market cap of $131.76M and a P/E ratio of 0.00. GRX moved +0.78% today. Year to date, GRX is -6.05%; over the trailing twelve months it is -6.24%. Its 52-week range spans $8.90 to $11.15. Rallies surfaces GRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on GRX?
Rallies AI research for GRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
GABELLI MARIO J bought 3.80K (~$36.40K) on Jan 12, 2026.
GABELLI MARIO J bought 1.01K (~$9.68K) on Jan 12, 2026.
GABELLI MARIO J bought 990 (~$9.48K) on Jan 8, 2026.
GRX Analyst Consensus
GRX analyst coverage data. Average price target: $0.00.
Common questions about GRX
What is the AI research view on GRX?
Rallies AI research for GRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for GRX?
Rallies AI research for GRX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is GRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GRX. It does not provide personalized investment advice.
